Literature DB >> 24474831

Alteplase: pleural effusion (parapneumonic) and empyema in children.

Joyce A Generali1, Dennis J Cada2.   

Abstract

This Hospital Pharmacy feature is extracted from Off-Label Drug Facts, a publication available from Wolters Kluwer Health. Off-Label Drug Facts is a practitioner-oriented resource for information about specific drug uses that are unapproved by the US Food and Drug Administration. This new guide to the literature enables the health care professional or clinician to quickly identify published studies on off-label uses and determine if a specific use is rational in a patient care scenario. References direct the reader to the full literature for more comprehensive information before patient care decisions are made. Direct questions or comments regarding Off-Label Drug Uses to jgeneral@ku.edu.

Entities:  

Year:  2013        PMID: 24474831      PMCID: PMC3875108          DOI: 10.1310/hpj4811-912

Source DB:  PubMed          Journal:  Hosp Pharm        ISSN: 0018-5787


  11 in total

Review 1.  Tissue plasminogen activator as an adjuvant therapy for pleural empyema in pediatric patients.

Authors:  Theresa L Ray; John W Berkenbosch; Pierantonio Russo; Joseph D Tobias
Journal:  J Intensive Care Med       Date:  2004 Jan-Feb       Impact factor: 3.510

2.  BTS guidelines for the management of pleural infection in children.

Authors:  I M Balfour-Lynn; E Abrahamson; G Cohen; J Hartley; S King; D Parikh; D Spencer; A H Thomson; D Urquhart
Journal:  Thorax       Date:  2005-02       Impact factor: 9.139

Review 3.  Current treatment of pediatric empyema.

Authors:  John A Hawkins; Eric S Scaife; Neal D Hillman; G Peter Feola
Journal:  Semin Thorac Cardiovasc Surg       Date:  2004

4.  The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America.

Authors:  John S Bradley; Carrie L Byington; Samir S Shah; Brian Alverson; Edward R Carter; Christopher Harrison; Sheldon L Kaplan; Sharon E Mace; George H McCracken; Matthew R Moore; Shawn D St Peter; Jana A Stockwell; Jack T Swanson
Journal:  Clin Infect Dis       Date:  2011-08-31       Impact factor: 9.079

Review 5.  Medical and surgical treatment of parapneumonic effusions : an evidence-based guideline.

Authors:  G L Colice; A Curtis; J Deslauriers; J Heffner; R Light; B Littenberg; S Sahn; R A Weinstein; R D Yusen
Journal:  Chest       Date:  2000-10       Impact factor: 9.410

6.  Intrapleural fibrinolysis for parapneumonic effusion and empyema in children.

Authors:  Robert G Wells; Peter L Havens
Journal:  Radiology       Date:  2003-08       Impact factor: 11.105

7.  Management of complicated parapneumonic effusions in children.

Authors:  G Peter Feola; Lt Corey A Shaw; Laurie Coburn
Journal:  Tech Vasc Interv Radiol       Date:  2003-12

8.  Effectiveness and safety of tissue plasminogen activator in the management of complicated parapneumonic effusions.

Authors:  Michael Weinstein; Ricardo Restrepo; Peter G Chait; Bairbre Connolly; Michael Temple; Colin Macarthur
Journal:  Pediatrics       Date:  2004-03       Impact factor: 7.124

9.  Thoracoscopic decortication vs tube thoracostomy with fibrinolysis for empyema in children: a prospective, randomized trial.

Authors:  Shawn D St Peter; Kuojen Tsao; Troy L Spilde; Scott J Keckler; Christopher Harrison; Mary Ann Jackson; Susan W Sharp; Walter S Andrews; Doug C Rivard; Frank P Morello; George W Holcomb; Daniel J Ostlie
Journal:  J Pediatr Surg       Date:  2009-01       Impact factor: 2.545

10.  Intrapleural hemorrhage due to alteplase use in a 6-year-old boy with pleural effusion.

Authors:  Mohamed A Hendaus; Ahmad Abushahin
Journal:  Int J Gen Med       Date:  2013-04-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.